Find therapies in clinical trials near you – page 481

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Study on the Effects of HZN-1116 for Patients with Sjögren’s Syndrome

Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis

Study on the Effects of Vibozilimod for Adults with Moderate to Severe Atopic Dermatitis

Study on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications

Study on PRAX-628 for Adults with Focal Epilepsy Taking 1 to 3 Anti-Seizure Medications

Study on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia

Study on Basimglurant for Treating Pain in Patients with Trigeminal Neuralgia

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

Study on Ublituximab for Patients with Relapsing Multiple Sclerosis

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Axial Spondyloarthritis

Phase 3 Study of ZIGAKIBART (BION-1301) in Adults with IgA Nephropathy

Safety and Immunogenicity of SARS-COV-2 VIRUS, VARIANT LP.8.1, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HOMODIMER Vaccine in Adults with COVID-19

Safety and Immunogenicity of SARS-COV-2 VIRUS, VARIANT LP.8.1, SPIKE PROTEIN, RECEPTOR BINDING DOMAIN FUSION HOMODIMER Vaccine in Adults with COVID-19

Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

Safety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone